AGs Reach $272.5 Million Settlement of Opioid-Epidemic Related Claims Against Amneal Pharmaceuticals
A coalition of AGs reached a settlement in principle with Amneal Pharmaceuticals, Inc., to resolve allegations that it contributed to the opioid epidemic in its role as a drug manufacturer. According to the coalition, Amneal allegedly knowingly failed to monitor and report suspicious orders placed by its customers, as required by federal law. Under the…